Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: A clinicopathologic case study-Reference-Cited by-同舟云学术

Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: A clinicopathologic case study

Published:2020-12 Issue: Volume:20 Page:100989
ISSN:2451-9936
Container-title:American Journal of Ophthalmology Case Reports
language:en
Short-container-title:American Journal of Ophthalmology Case Reports

Author:

Iyer Prashanth G.,Peden Marc C.^ORCID,Suñer Ivan J.,Patel Nish^ORCID,Dubovy Sander R.,Albini Thomas A.

Funder

Florida Lions Eye Bank

Publisher

Elsevier BV

Subject

Ophthalmology

Reference29 articles.

1. Brolucizumab versus aflibercept in participants with neovascular age-related macular degeneration: a randomized trial;Dugel;Ophthalmology,2017

2. Affinity and potency of RTH258 (ESBA1008), a novel inhibitor of vascular endothelial growth factor alpha for the treatment of retinal disorders;Tietz;Invest Ophthalmol Vis Sci,2015

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation and Vasculitis Related to Brolucizumab;Journal of Clinical Medicine;2024-09-02

2. Brolucizumab-associated intraocular inflammation in Indian patients by VRSI study group;Indian Journal of Ophthalmology;2024-07-29

3. Retreatment with faricimab in prior brolucizumab-related intraocular inflammation eyes;Taiwan Journal of Ophthalmology;2024-04-26

4. Intraocular Inflammation with faricimab: insights from Manufacturer and User Facility Device Experience (MAUDE) database;Eye;2024-04-24

5. Mimickers of anterior uveitis, scleritis and misdiagnoses- tips and tricks for the cornea specialist;Journal of Ophthalmic Inflammation and Infection;2024-04-10